Company news
Pascal Biosciences Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Rob Gietl Joins Pascal Biosciences as New Chief Executive Officer
September 7, 2021
Hardy Forzley Joins Pascal Biosciences as Chief Financial Officer
June 16, 2021
InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Cancer Institute Grant for its Acute Lymphoblastic Leukemia Program - Video Available on Investmentpitch.com
June 9, 2021
Pascal Biosciences Awarded NIH Grant For Leukemia Program
June 8, 2021
Pascal Biosciences Announces New OTC Markets Trading Symbol PSCBF
May 31, 2021
Pascal Biosciences Announces Management Changes
March 22, 2021
Pascal Biosciences Inc. Closes Second Tranche of Non-Brokered Private Placement of $750,000
March 17, 2021
Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit
January 21, 2021
Pascal Biosciences and S?RSE Technology Optimize Cannabinoid Formulation for Clinical Development of Cancer Treatment
December 8, 2020
Pascal Biosciences Appoints Mark van der Horst as Vice President of Corporate Communications
November 10, 2020
Pascal Biosciences Confirms Specific Cannabinoids Combat Coronavirus
September 23, 2020
Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceutical Summit
September 16, 2020
Pascal Biosciences and S?RSE Technology Announce Partnership for Cannabinoid Drug Development and Cancer Clinical Trials
September 14, 2020
Pascal Biosciences Announces Listing on the Frankfurt Stock Exchange
August 4, 2020
Pascal Biosciences Announces Feature Article
July 17, 2020
Pascal Biosciences Discovers a Cannabinoid That Combats Coronavirus
July 14, 2020
Pascal Biosciences Appoints Dr. Michael Shepard to Board of Directors
July 9, 2020